Leprosy Mailing List – January 27, 2018
Ref.: (LML) Chemoprophylaxis in Leprosy
From: Wim van Brakel, Amsterdam, the Netherlands
I would like to react to the remark by Dr. Romero (LML, January 24, 2018) regarding the risk of developing Rifampicin resistance in case of chemoprophylaxis in leprosy.
High-level TB experts involved in work on MDR TB have assured us that single-dose rifampicin chemoprophylaxis does not pose a risk for inducing rifampicin-resistant TB. It is of course important that proper precautions and screening procedures are in place, as detailed in the attached paper.
With kind regards,
Wim van Brakel, MD MSc PhD
Head Technical Department
Netherlands Leprosy Relief (NLR)
Tel. +31 20 5950529
LML - S Deepak, B Naafs, S Noto and P Schreuder
LML blog link: http://leprosymailinglist.blogspot.it/
Contact: Dr Pieter Schreuder << email@example.com